Sysmex Announces Establishment
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Ratan Tata ~ Pranab Mukherjee ~ Forex Rates ~ Bullion Rates ~ RBI ~ SEBI ~ Stock Markets
Home / Business News / 2010 / January 2010 / January 13, 2010
Sysmex Announces Establishment of Overseas Subsidiary in Spain to Expand Life Science Business
RSS / Print / Comments

Breast cancer

Sysmex Announces Establishment of Overseas Subsidiary in Spain to Expand Life Science Business

Breast cancer multigene test may help patients avoid chemo

Mangoes may protect against breast, colon cancer

More on Breast cancer

Top News

144 Section in Hyderabad ahead of Ayodhya verdict

18 killed, several injured as bus falls into river in Bulandshahr

Pak's flawed Afghan policy of support to terror groups will bite back hard: Editorial

Ajay Devgan prays for success of his film in Ajmer

Pranab Mukherjee seeks more financial sector reforms

Australia asks CWG organizers for better treatment at closing ceremony

Study to find whether leptin helps type 1 diabetic patients

New study confirms smoking, cancer link (reissue)

Sysmex Announces Establishment of Overseas Subsidiary in Spain to Expand Life Science Business

Kobe, Jan 13, 2010 - (JCN Newswire) - Sysmex Corporation today announced that it established Sysmex Espana S.L. in Barcelona Spain on January 1 2010 to further expand its Life Science business in that country. The company will provide comprehensive sales and after-sales support services for its life science-related products in Spain.

Sysmex started its life science business in Europe in 2008 ahead of other regions and, has expanded the business steadily since that time. In Spain sentinel lymph-node histopathological diagnosis for breast cancer screening is well advanced in Europe and, Sysmex products have enjoyed a high reputation with contoinuously increasing number of installations.

Sysmex established Sysmex Espana S.L. to reinforce direct sales and after-sales support activities for its Life Science products in Spain, thereby accelerating the respective expansion through an own local presence and the respecive proximity to its clients. By further promoting the intraoperative diagnosis of sentinel lymph node the company will contribute to improve diagnostic efficiency and accuracy thus contributing to the patients' quality of life.

Sysmex will also continue its expansion in Life Science business in other European countries.

Outline of the new subsidiary

Name: Sysmex Espana S.L.

Location: Barcelona, Spain

Representatives: Fernando Andreu

Established: January 1, 2010

Capital supplied by: Sysmex Europe GmbH

(Sysmex Europe GmbH is a 100% subsidiary

of Sysmex Corporation)

Employees: 7 (FY2009)

Line of business: Sales and after-sales support for Life Science

products in Spain

Sysmex Life Science Product

It is regarded as desirable to minimize the extent of lymph node dissection in breast cancer treatment for the patient's quality of life (QOL). At present, the pathology lab offers a provisional diagnostic of the sentinel lymph node, where the metastasized cancer cells first reach, intra-operatively and then does a confirmatory study after the surgery to determine the extent of resection as well as, the post-surgical therapeutic principle. Intra-operative diagnosis of cancer metastasis requires highly skilled and experienced surgeons. Sysmex's gene amplification detector RD-100i enables the detection of breast cancer metastases in sentinel lymph node in approximately 30 minutes, thus facilitating intra-operative diagnosis to reduce the need for further surgery*. This consequently reduces the burden on patients while reducing overall case costs.

Sysmex is also doing intensive research and development to extend the usage of this diagnostic principle further into colorectal, gastric and other types of cancer.

* If any metastasis is detected post-operatively with conventional testing methods, an additional surgical intervention or other treatment is required.

About Sysmex

Sysmex Corporation is a global supplier of clinical laboratory testing devices, reagents and software for hematology, hemostasis, immuno-chemistry, particle counting and urinalysis. Sysmex Corporation is distributing its comprehensive products in more than 125 countries and counted as one of the top ten diagnostics companies worldwide. Sysmex Corporation is a technology oriented company and committed to contribute to a healthy society by developing innovative technologies for clinical laboratory testing as well as new core technologies in life sciences. Please visit

Source: Sysmex



IR / Corporate Communication Div.

Tel: +81-78-265-0508

Fax: +81-78-265-0527


Copyright 2009 JCN Newswire. All rights reserved.

ACN Newswire

Link to this page

Suggested pages for your additional reading on Facebook

© 2000-2017 All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us